ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.
Posted by: ArcScan in Press Releases
GOLDEN, Colo., July 21, 2021 /PRNewswire/ — ArcScan, Inc., the developer of state-of-the-art ophthalmic ultrasound imaging device “ArcScan Insight® 100, ” headquartered in Golden, Colorado, announces the execution of a Stock Purchase Agreement with Shanghai Haohai Biological Technology Ltd. (“Haohai”) that will result in a $11.15 million Preferred Series B investment into ArcScan, Inc. Haohai is a leading Chinese ophthalmology and medical… Read More
ArcScan Announces Sale of Insight® 100 Device for Ophthalmic Imaging to Walter Reed Medical Center and Naval Hospital Camp LeJeune
Posted by: ArcScan in Press Releases
ArcScan, Inc., developer of state-of-the-art ophthalmic imaging technology, announced today that the company has closed sales for its Insight® 100 device to Walter Reed National Military Medical Center in Bethesda, MD, and Naval Hospital Camp Lejeune in Jacksonville, NC. GOLDEN, Colo. (PRWEB) November 06, 2017 — ArcScan, Inc., developer of state-of-the-art ophthalmic imaging technology, announced… Read More